Tessa Therapeutics, in Collaboration with Baylor College of Me...
SINGAPORE, April 30, 2019 /PRNewswire-AsiaNet/ -- - Preclinical, 'proof-of-concept' results for a novel 'all-in-one' immunotherapy for the treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-positive solid tumors- The preclinical findings support the advancement of this multimodal immu...
Authors: LATEST ASIANET NEWS RELEASES